Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ozempic by Novo Nordisk for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
Ozempic is under clinical development by Novo Nordisk and currently in Pre-Registration for Chronic Kidney Disease (Chronic Renal Failure). According...
Data Insights
Ozempic by Novo Nordisk for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD): Likelihood of Approval
Ozempic is under clinical development by Novo Nordisk and currently in Phase III for Peripheral Arterial Disease (PAD)/ Peripheral Vascular...